Miltenyi’s workflow for immuno-oncology target discovery and validation

Invitation to the Miltenyi Biotec seminar
We combined high-throughput flow cytometry and high-content cyclic
immunofluorescence for the identification of target candidates for cellular
immunotherapy of pancreatic ductal adenocarcinoma (PDAC). We guide the
attendees through our recent scientific findings and related tools, ranging
from the preparation of tumor samples to antigen screening and phenotyping.
Flow Cytometry Core Facility& Miltenyi Biotec

Miltenyi’s workflow for immuno-oncology
target discovery and validation

Monday, February 27, 2023
10:00 a.m.–12:00 p.m.
BMZ II, Room B012. EG. Foyer

AGENDA:

10:00 Welcome
Andreas Dolf, Core Facility Manager
and Dr. Verena Barbarino, Account Manager
Research, Miltenyi Biotec
10:15 Introducing the Flow Cytometry Core Facility
Andreas Dolf, Core Facility Manager
10:30 The power of high-throughput flow
cytometry combined with high-content cyclic
immunofluorescence
Dr. Olaf Hardt, R&D, Miltenyi Biotec
and Dr. Daniel Schäfer, R&D, Miltenyi Biotec
11:30 Break with sandwiches
from 12:30 [With pre-registration*]
Hands-on experience on Miltenyi’s
MACSQuant® Flow Cytometer and autoMACS®
NEO Cell Separator

Dr. Verena Schmitt, Application Specialist Flow
Cytometry, Miltenyi Biotec
* For the hands-on part pre-register with Andreas Dolf. (andreas.dolf@uni-bonn.de)